Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

The US Food and Drug Administration (USFDA) questioned India's top drugmaker Sun Pharma for alleged failures in preventing ...

Sun Pharmaceutical Industries began with just 5 products to treat psychiatry ailments in 1983. Sales were initially limited to 2 states – West Bengal and Bihar. Sales were rolled out nat..

An import alert may follow a warning letter or OAI classification if the FDA is not satisfied with ... subject to the exemption of certain products. Sun Pharmaceutical Industries' Halol facility ...

A Boca Raton pharmaceutical company has agreed to settle charges with the Food and Drug Administration that allege improper ...

Dear Fellow Shareholders / Ladies and Gentlemen: On behalf of the Board of Directors I take pleasure in welcoming all of you to the 4th AGM of your c... Your Directors take pleasure in presenting ...

"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the ...

The deal is the Indian drugmaker's biggest since its $3.2 billion acquisition of generic drugmaker Ranbaxy Laboratories Ltd ...

According to Sun Pharma, Palbociclib is approved by the US Food and Drugs Administration (FDA), European Medicines Agency ...

Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma’s Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients ...